Clinical trial Recruiting at 4 sites Observational Ages 28 Days to 65

Understanding congenital bone marrow failure and related disorders through a national network

Official title: Potenziare la Gestione Clinica Delle CMF Attraverso Una Rete Nazionale Pediatrica e Dell'Adulto Basata su Dati Biologici e Genetici / Enhancing the Clinical Management of CMF Through a National Pediatric and Adult Network Based on Biological and Genetic Data

Run by Istituto Giannina Gaslini · NCT07877727 · Data updated 2026-11-12

This project tests whether people with rare inherited bone marrow failure syndromes or related conditions really have the underlying genetic causes, by collecting data and samples across multiple centers.

Quick facts

Study typeObservational
Ages28 Days to 65 Years
SexAll
Enrollment250 (estimated)
SponsorIstituto Giannina Gaslini
Academic / other
Locations4 sites (Avellino and 3 other locations)
StatusRecruiting
StartedMay 29, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedOctober 16, 2026
Trial IDNCT07877727 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Individuals diagnosed with Fanconi anemia, dyskeratosis congenita and other telomere biology disorders, congenital neutropenia, primary immune regulatory disorders, congenital amegakaryocytic thrombocytopenia, or acquired aplastic anemia, with or without paroxysmal nocturnal hemoglobinuria, and who can provide informed consent/assent.

Probably not a fit

Participants without the specified conditions or without available biospecimens or complete data may not directly benefit from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, translational study enrolling patients with Fanconi anemia, dyskeratosis congenita, telomere biology disorders, congenital neutropenia, and related disorders to better define clinical and genetic features. It uses retrospective and prospective data collection and sample processing to identify disease-specific biomarkers and to clarify misdiagnoses between constitutional marrow failure and idiopathic cases. The goal is to characterize well-defined cohorts based on clinical history, manifestations, and immune findings, to improve understanding of underlying etiologies. No interventions are described in the protocol here; study activities focus on data collection, sample analysis, and observational correlations. The study is conducted across multiple Italian institutions under a national network.

Why it matters

Potential benefit: If successful, participants and future patients could receive more precise genetic and clinical classification, guiding prognosis and management.

How similar studies have gone: Previous research in CMF and related bone marrow failure conditions has shown that careful phenotyping and biomarker work can reveal underlying etiologies, though the integration of broader networks in this protocol represents a widening of scope.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with Fanconi anemia (FA), dyskeratosis congenita (DC) and other telomere biology disorders (TBD), congenital neutropenia (CN), primary immune regulatory disorders (PIRD), congenital amegakaryocytic thrombocytopenia (CAMT), and acquired aplastic anemia (AAA), with or without paroxysmal nocturnal hemoglobinuria (PNH).
* Signed informed consent and/or assent obtained from the participant and/or their parents or legal guardians, as applicable.

Exclusion Criteria:

* Absence of signed informed consent and/or assent from the participant and/or their parents or legal guardians

Where it's running

  • AORN San Giuseppe Moscati Hematology and bone marrow Transplant Unit
    Avellino, Italy
    Recruiting
  • IRCCS Istituto Giannina Gaslini
    Genova, Italy
    Recruiting
  • Azienza Ospedaliera di Rilievo Nazionale Santobono Pausilipon Dipartimento di oncologia, ematologia e terapie cellulari
    Naples, Italy
    Recruiting
  • Università degli Studi di Verona Department of Engineering for Innovation Medicine
    Verona, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Reduced intensity bone marrow transplant for immune and bone marrow disorders

    This study is testing a gentler type of bone marrow transplant to see if it can help people with immune and bone marrow disorders recover better and live longer.

    Recruiting Phase 2 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland · NCT04232085

  • Transplantation for inherited bone marrow failure disorders

    This study is testing a new way to do stem cell transplants for people with inherited bone marrow failure disorders to see if it can help them recover faster and reduce the risk of infections without needing extra medication.

    Recruiting Phase 2 Masonic Cancer Center, University of Minnesota · Minneapolis, Minnesota · NCT03579875

  • Using CD45RA Depleted Stem Cells to Prevent Infections After Transplant

    This study is testing whether using special stem cells can help patients with high-risk leukemia recover their immune system faster and prevent infections after a stem cell transplant.

    Recruiting Phase 1/2 Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT06839456

  • Understanding Squamous Cell Carcinoma in People with Fanconi Anemia

    This study looks at how squamous cell carcinoma develops in people with Fanconi anemia to help catch it early and improve treatment options.

    Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT05687149

  • Investigating genetic factors in childhood cancer

    This study is trying to find out if certain genes passed down in families can increase the risk of childhood cancer by looking at samples from kids who have had cancer and their relatives.

    Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT03050268

  • Investigation of genetics related to blood diseases

    This study is trying to understand the genetics behind blood diseases by collecting samples and health information from people with these conditions and their family members.

    Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT02720679

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.